The anti-tumor effects related to the blocking of PI3K signaling is not only due to the inhibition of the pro-survival mechanism mediated by its downstream effectors (e.g., AKT or mTORC1) but also associated with tumor microenvironment modulation. The gene discussed is PIK3CB; the disease is neoplasm.